Piedmont Office Realty Trust (NYSE:PDM – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued on Friday.
Piedmont Office Realty Trust Price Performance
Shares of PDM opened at $7.20 on Friday. Piedmont Office Realty Trust has a 12 month low of $4.91 and a 12 month high of $8.05. The company has a debt-to-equity ratio of 1.23, a current ratio of 1.90 and a quick ratio of 1.90. The stock has a fifty day moving average price of $7.00 and a 200 day moving average price of $6.86. The company has a market cap of $892.01 million, a P/E ratio of -11.80 and a beta of 1.19.
Piedmont Office Realty Trust (NYSE:PDM – Get Free Report) last announced its quarterly earnings results on Tuesday, April 30th. The real estate investment trust reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.39 by ($0.61). Piedmont Office Realty Trust had a negative net margin of 12.90% and a negative return on equity of 4.29%. The firm had revenue of $144.54 million for the quarter, compared to analyst estimates of $143.41 million. On average, research analysts forecast that Piedmont Office Realty Trust will post 1.5 earnings per share for the current year.
Institutional Trading of Piedmont Office Realty Trust
Piedmont Office Realty Trust Company Profile
Piedmont Office Realty Trust, Inc (also referred to herein as "Piedmont" or the "Company") (NYSE: PDM) is an owner, manager, developer, redeveloper and operator of high-quality, Class A office properties located primarily in major U.S. Sunbelt markets. The Company is a fully-integrated, self-managed real estate investment trust ("REIT") with local management offices in each of its markets and is investment-grade rated by Standard & Poor's and Moody's.
Featured Articles
- Five stocks we like better than Piedmont Office Realty Trust
- How to Use the MarketBeat Dividend Calculator
- McDonald’s Stock: Balancing Value and Innovation
- How to invest in marijuana stocks in 7 steps
- MarketBeat Week in Review – 6/17 – 6/21
- What Are Dividend Challengers?
- Sarepta Therapeutics Stock Soars on FDA Approval
Receive News & Ratings for Piedmont Office Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Piedmont Office Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.